PKMYT1 aggravates the progression of ovarian cancer by targeting SIRT3.

Xuan, Z-H; Wang, H-P; Zhang, X-N; Chen, Z-X; Zhang, H-Y; Gu, M-M

Xuan, Z-H; Wang, H-P; Zhang, X-N; Chen, Z-X; Zhang, H-Y; Gu, M-M.

Affiliation

Xuan ZH; Department of Obstetrics and Gynecology, Jinan Second Maternal and Child Health Hospital, Jinan, China. lwxuanzhenhua@163.com.

Eur Rev Med Pharmacol Sci ; 24(10): 5259-5266, 2020 05.

Article in En | MEDLINE | ID: mdl-32495859

Subject(s)

Membrane Proteins/metabolism; Ovarian Neoplasms/metabolism; Protein Serine-Threonine Kinases/metabolism; Protein-Tyrosine Kinases/metabolism; Sirtuin 3/metabolism; Cells, Cultured; Female; Humans; Membrane Proteins/genetics; Middle Aged; Ovarian Neoplasms/pathology; Protein Serine-Threonine Kinases/genetics; Protein-Tyrosine Kinases/genetics; Sirtuin 3/genetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Protein-Tyrosine Kinases / Protein Serine-Threonine Kinases / Sirtuin 3 / Membrane Proteins Limits: Female / Humans / Middle aged Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2020 Document type: Article Affiliation country: China Country of publication: Italy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google